Supportive Oligonucleotide Therapy
SOT is a DNA sequenced IV treatment of tick born illnesses, viruses and some cancers.
How does SOT work?
Essentially SOT creates a shutoff “key” that precisely fits a chosen “lock” portion of a pathogen. The “lock” is a specific section of DNA that normally controls an important function of the pathogen. The “key” binds to the “lock” and blocks the function thus eliminating the pathogen. Afterwards, the SOT compound is released and travels to the next target, thus fighting the infection 24/7 for 3 to 6 months. (Source)
What kind of cancers can be treated with the SOT Therapy?
• Solid tumors
• Hematological malignancies
What kind of viruses can be treated with the SOT THERAPY?
• Herpes Simplex Virus (HSV) 1 and 2,
• Varicella Zoster Virus (VZV),
• Epstein-Barr Virus (EBV),
• Human Papilloma Virus (HPV) 16/18,
• HTLV1, Hepatitis B Virus,
• Hepatitis C Virus,
• Human Immunodeficiency Virus (HIV),
• Coxsackie Virus Type A & B.
What species of Lyme and co-infections be treated with the SOT Therapy?
There is a list provided by RGCC that gives the Lyme and co-infection targets available for SOT
(Borrelia, Bartonella and Babesia and other tick borne bacterial diseases).
Is SOT therapy safe?
Yes, they have been assessed in thousands of studies for their safety. You can read more information from the FDA here.
You can also learn more about the science behind SOT therapy in this video below.